Annalisa Jenkins, Chief Executive Officer of Dimension, said, "Our portfolio of liver-directed gene therapy programs is advancing towards the clinic and multiple regulatory milestones. The ...

Aptuit LLC, a premier global drug discovery and development CRO, and Dimension Therapeutics, a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the ...

We will continue to develop academic programs at all degree levels that are the first of their kind and that capitalize upon our core strengths in technology, art, and design. We will complement our ...

DIMENSION株式会社（本社：東京都港区、代表取締役社長：宮宗 孝光、以下 DIMENSION）は、2024年5月15日（水）～16日（木）に日本・東京にて開催される、グローバルイノベーションカンファレンス「SusHi Tech Tokyo 2024 Global Startup Program(スシテックトウキョウ2024 ...

Dimension Data on Monday introduced the Adoption Management Program (AMP), a plan through which Dimension will sell services to enterprises to help drive use of new UC technologies internally, offer ...